PUBLISHER: The Business Research Company | PRODUCT CODE: 2149441
PUBLISHER: The Business Research Company | PRODUCT CODE: 2149441
Bioabsorbable surgical fixation devices are temporary implantable medical products manufactured using biodegradable polymers to provide mechanical stabilization for fractured bones, repaired ligaments, and other musculoskeletal tissues during the healing process. These devices deliver the required fixation and structural support throughout tissue regeneration and subsequently degrade gradually through natural biological processes into biocompatible by-products that can be metabolized or eliminated by the body. These devices help minimize the need for additional surgical interventions, enhance patient comfort, reduce healthcare expenses, and support more efficient postoperative recovery.
The primary product types of bioabsorbable surgical fixation devices include bioabsorbable screws, bioabsorbable pins, bioabsorbable plates, bioabsorbable suture anchors, and other product types. Bioabsorbable screws refer to fixation devices developed to stabilize tissues or bone structures throughout the healing process and gradually degrade within the body over time. These devices are manufactured from polylactic acid, polyglycolic acid, polycaprolactone, poly lactic-co-glycolic acid, and other material types. They are utilized in orthopedic surgery, craniofacial surgery, and other procedures, serving end users including hospitals, ambulatory surgical centers, specialty orthopedic clinics, and trauma centers.
Tariffs are influencing the bioabsorbable surgical fixation devices market by increasing the cost of imported biodegradable polymers, specialized medical-grade materials, precision manufacturing equipment, and implant components required for manufacturing fixation devices. This is raising production expenses and may influence pricing and availability across orthopedic surgery, craniofacial surgery, and other surgical applications, particularly in regions dependent on imported medical devices and raw materials such as North America, Europe, and Asia-Pacific. Product types such as bioabsorbable screws, plates, pins, and suture anchors are particularly affected due to their dependence on specialized materials and precision manufacturing processes. However, tariffs are also promoting regional sourcing, domestic manufacturing, supplier diversification, and greater investment in local medical device production, strengthening long-term supply chain resilience.
The bioabsorbable surgical fixation devices market research report is one of a series of new reports from The Business Research Company that provides bioabsorbable surgical fixation devices market statistics, including bioabsorbable surgical fixation devices industry global market size, regional shares, competitors with a bioabsorbable surgical fixation devices market share, detailed bioabsorbable surgical fixation devices market segments, market trends and opportunities, and any further data you may need to thrive in the bioabsorbable surgical fixation devices industry. This bioabsorbable surgical fixation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioabsorbable surgical fixation devices market size has grown strongly in recent years. It will grow from $1.18 billion in 2025 to $1.24 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to the rising occurrence of orthopedic injuries and fractures, increasing demand for minimally invasive surgical interventions, growing preference for implants that avoid subsequent removal procedures, expanding adoption of biodegradable medical materials, and increasing emphasis on minimizing postoperative complications.
The bioabsorbable surgical fixation devices market size is expected to see strong growth in the next few years. It will grow to $1.56 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing demand for effective musculoskeletal tissue healing, growing adoption of bioabsorbable fixation technologies in sports medicine, rising need to enhance patient comfort following orthopedic procedures, expanding application of biodegradable fixation solutions for ligament and bone repair, and increasing demand to lower healthcare expenses associated with implant removal. Major trends in the forecast period include growing adoption of bioabsorbable fixation devices in orthopedic treatments, rising preference for temporary fixation solutions that avoid subsequent implant removal procedures, increasing use of biodegradable polymers for musculoskeletal tissue stabilization, growing demand for minimally invasive fixation techniques, and expanding adoption of bioabsorbable devices to support improved postoperative recovery.
The increasing demand for minimally invasive surgeries is expected to propel the growth of the bioabsorbable surgical fixation devices market going forward. Minimally invasive surgery refers to surgical procedures that use small incisions and specialized instruments to repair bone and soft tissue injuries. Minimally invasive surgeries are increasing due to growing patient preference for faster recovery, as these procedures reduce tissue damage, postoperative pain, hospital stays, and recovery time compared to conventional open surgeries. Bioabsorbable surgical fixation devices complement these procedures by providing temporary bone and soft tissue fixation without requiring a second surgery for implant removal, thereby reducing the overall patient burden while supporting efficient healing and improved clinical outcomes. For example, in June 2025, according to NHS England, a UK-based government department, around 70,000 robot-assisted minimally invasive surgeries were performed across the NHS in 2023-24. The NHS aims to increase this figure to 500,000 procedures annually by 2035, with 90% of eligible keyhole surgeries expected to be robot-assisted, reflecting the growing adoption of minimally invasive surgical techniques. Therefore, the increasing demand for minimally invasive surgeries is expected to drive the growth of the bioabsorbable surgical fixation devices market.
Leading companies operating in the bioabsorbable surgical fixation devices market are focusing on technological advancements in bioabsorbable polymers, such as bio-integrative mineral-fiber composite technology, to develop high-strength implants that promote bone integration, eliminate the need for implant removal surgeries, and improve long-term clinical outcomes. Bio-integrative mineral-fiber composite technology refers to the use of a composite material that combines bioactive mineral components with reinforcing fibers to create medical or surgical devices that can integrate with surrounding biological tissue. For example, in June 2025, OSSIO Inc., a US-based medical technology company, launched OSSIOfiber 2.5mm Suture Anchors. The anchors offer a smaller profile for procedures such as Brostrom repair, deliver 55% greater pull-out strength than the leading 2.4mm bio-composite anchor, and contain no metal, reducing the risk of adverse tissue reactions. This launch strengthens the soft tissue fixation portfolio and builds surgeon confidence in metal-free fixation, although high production costs continue to limit broader adoption.
In July 2024, Stryker Corporation, a US-based medical technology company offering orthopaedic implants, surgical equipment, neurotechnology, and spine solutions, acquired Artelon Inc. for an undisclosed amount. Through this acquisition, Stryker sought to reinforce its soft tissue fixation portfolio and broaden its comprehensive product offerings across the foot and ankle and sports medicine segments, strengthening its competitive standing in the wider bioabsorbable and biosynthetic fixation devices market. Artelon Inc. is a US-based company that develops soft tissue fixation products based on proprietary bioresorbable polymer technology, including systems used for ligament and tendon reconstruction.
Major companies operating in the bioabsorbable surgical fixation devices market are Johnson & Johnson, Stryker Corporation, Medtronic plc, Zimmer Biomet Holdings Inc, Smith & Nephew plc, Arthrex Inc, B Braun SE, CONMED Corporation, Gebruder Martin GmbH & Co KG, Teijin Medical Technologies Co Ltd, Anika Therapeutics Inc, Acumed LLC, Gunze Limited, OSSIO Inc, Bioretec Ltd, Inion Oy, Osteopore International Pte Ltd, Jeil Medical Corporation, SBM SAS, Orthomed SAS, Matricel GmbH, Tulpar Medical Solutions
North America was the dominating region in the bioabsorbable surgical fixation devices market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the bioabsorbable surgical fixation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bioabsorbable surgical fixation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bioabsorbable surgical fixation devices market consists of sales of bioabsorbable staples, bioabsorbable tacks, bioabsorbable washers and bioabsorbable rods. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioabsorbable Surgical Fixation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses bioabsorbable surgical fixation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bioabsorbable surgical fixation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioabsorbable surgical fixation devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope are limited to 20% of content and consultant support time is limited to 8 hours.